Cellectis (CLLS) Inventory Average (2017 - 2021)
Cellectis (CLLS) recorded quarterly Inventory Average of $2.1 million in Q3 2021, down 46.78% quarter-over-quarter from $3.9 million in Q2 2021, and down 65.4% on a YoY basis from $6.0 million in Q3 2020.
Cellectis (CLLS) Inventory Average (2017 - 2021) Analysis & Trends
Cellectis' Inventory Average history runs 5 years deep, the most recent figure standing at $2.1 million for Q3 2021.
- In Q3 2021, Inventory Average fell 65.4% year-over-year to $2.1 million; the TTM figure through Sep 2021 stood at $2.1 million (down 65.4% YoY), while the FY2020 annual figure was $2.2 million, up 41.77% from the prior year.
- Inventory Average was $2.1 million for Q3 2021 at Cellectis, down from $3.9 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $6.0 million in Q3 2020 to a low of $116931.1 in Q1 2017.
- Historically, Inventory Average has averaged $1.9 million across 5 years, with a median of $1.0 million in 2019.
- The sharpest annual moves came in 2019 and 2021: Inventory Average jumped 1153.21% in 2019, then slumped 65.4% in 2021.
- A 5-year view of Inventory Average shows it stood at $187500.0 in 2017, then surged by 32.8% to $249000.0 in 2018, then surged by 1153.21% to $3.1 million in 2019, then rose by 25.97% to $3.9 million in 2020, then plunged by 47.32% to $2.1 million in 2021.
- The last three Inventory Average figures came in at $2.1 million (Q3 2021), $3.9 million (Q2 2021), and $3.5 million (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2.07 Mn |
| Jun 30, 2021 | 3.89 Mn |
| Mar 31, 2021 | 3.46 Mn |
| Dec 31, 2020 | 3.93 Mn |
| Sep 30, 2020 | 5.99 Mn |
| Jun 30, 2020 | 4.65 Mn |
| Mar 31, 2020 | 3.24 Mn |
| Dec 31, 2019 | 3.12 Mn |
| Sep 30, 2019 | 2.17 Mn |
| Jun 30, 2019 | 1.02 Mn |
| Mar 31, 2019 | 664,500.00 |
| Dec 31, 2018 | 249,000.00 |
| Sep 30, 2018 | 227,000.00 |
| Jun 30, 2018 | 217,000.00 |
| Mar 31, 2018 | 226,500.00 |
| Dec 31, 2017 | 187,500.00 |
| Sep 30, 2017 | 125,174.31 |
| Jun 30, 2017 | 119,140.88 |
| Mar 31, 2017 | 116,931.12 |